- Home
- PAVS vs PRFX Comparison
PAVS vs PRFX Comparison
Compare PAVS & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVS | PRFX |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.8M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PAVS | PRFX |
|---|---|---|
| Price | $2.20 | $0.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.3M | 143.6K |
| Earning Date | 08-04-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,416,127.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18037.91 | N/A |
| 52 Week Low | $1.38 | $0.80 |
| 52 Week High | $150.00 | $6.65 |
Technical Indicators
Market Signals| Indicator | PAVS | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 68.97 | 38.71 |
| Support Level | $1.38 | $0.81 |
| Resistance Level | $3.83 | $0.91 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | 0.21 | -0.01 |
| Stochastic Oscillator | 56.47 | 6.29 |
Price Performance
Historical ComparisonAbout PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.